医学理论与实践
醫學理論與實踐
의학이론여실천
The Journal of Medical Theory and Practice
2014年
16期
2112-2113,2132
,共3页
朱明%韩卫卫%齐秋锋%包燕青%张亚平%刘永萍
硃明%韓衛衛%齊鞦鋒%包燕青%張亞平%劉永萍
주명%한위위%제추봉%포연청%장아평%류영평
细胞质胸苷激酶1(TK1)%肺癌
細胞質胸苷激酶1(TK1)%肺癌
세포질흉감격매1(TK1)%폐암
Thymidine kinase 1(TK1)%Lung cancer
目的:探讨细胞质胸苷激酶1(TK1)在肺癌患者血清中的水平及其对肺癌的诊断价值和复发评估作用。方法:检测28例肺癌患者术前、术后1周和术后1个月的血清 T K1水平,同时选取30例健康体检者作为对照。比较分析各组TK1水平差异以及术后TK1变化情况与肺癌患者无复发生存率(RFS)的相关性。结果:28例肺癌患者的 TK1平均浓度为(2.954±0.176)pM ,显著高于正常对照组的(1.063±0.163)pM(P<0.001),术后1个月 TK1水平较术前显著下降(1.801±0.176)pM (P<0.001),且术后1个月TK1水平评估为PR组的患者无复发生存率(RFS)显著高于SD+PD组( P<0.05)。结论:血清T K1作为一种新的肿瘤标志物,在肺癌的诊断和复发评估中有着潜在的应用价值。
目的:探討細胞質胸苷激酶1(TK1)在肺癌患者血清中的水平及其對肺癌的診斷價值和複髮評估作用。方法:檢測28例肺癌患者術前、術後1週和術後1箇月的血清 T K1水平,同時選取30例健康體檢者作為對照。比較分析各組TK1水平差異以及術後TK1變化情況與肺癌患者無複髮生存率(RFS)的相關性。結果:28例肺癌患者的 TK1平均濃度為(2.954±0.176)pM ,顯著高于正常對照組的(1.063±0.163)pM(P<0.001),術後1箇月 TK1水平較術前顯著下降(1.801±0.176)pM (P<0.001),且術後1箇月TK1水平評估為PR組的患者無複髮生存率(RFS)顯著高于SD+PD組( P<0.05)。結論:血清T K1作為一種新的腫瘤標誌物,在肺癌的診斷和複髮評估中有著潛在的應用價值。
목적:탐토세포질흉감격매1(TK1)재폐암환자혈청중적수평급기대폐암적진단개치화복발평고작용。방법:검측28례폐암환자술전、술후1주화술후1개월적혈청 T K1수평,동시선취30례건강체검자작위대조。비교분석각조TK1수평차이이급술후TK1변화정황여폐암환자무복발생존솔(RFS)적상관성。결과:28례폐암환자적 TK1평균농도위(2.954±0.176)pM ,현저고우정상대조조적(1.063±0.163)pM(P<0.001),술후1개월 TK1수평교술전현저하강(1.801±0.176)pM (P<0.001),차술후1개월TK1수평평고위PR조적환자무복발생존솔(RFS)현저고우SD+PD조( P<0.05)。결론:혈청T K1작위일충신적종류표지물,재폐암적진단화복발평고중유착잠재적응용개치。
Objective :To investigate the serum thymidine kinase 1(TK1) levels and its relevance in diagnosis and re-currence assessment of patients with lung cancer .Methods :Serum TK1 levels are detected in 28 cases of lung cancer pa-tients before surgery with 30 healthy persons as control to determine its diagnostic value .Then test the serum TK1 one week and one month respectively after surgical operation ,observe the changes and its relationship to relapse-free sur-vival (RFS) .Results:Average TK1 concentration of 28 patients with lung cancer (2 .954 ± 0 .176)pM was significantly higher than that in the healthy controls (1 .063 ± 0 .163)pM (P<0 .001) ,and it decreased significantly one month after surgery (1 .801 ± 0 .176)pM (P<0 .001) .Furthermore ,one month after surgery ,the relapse-free survival (RFS) of patients whose TK1 level achieved PR was significantly longer than that of SD +PD group (P<0 .05) .Conclusion:Ser-um TK1 as a new tumor marker has potential applications in the diagnosis and assessment of recurrence of lung cancer .